Table 3.

Adjusted Odds Ratios^* and 95% Confidence Intervals for Use of Medications for Cardiovascular Disease Prevention^** by Insurance Status and HPSA Classification at Baseline in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study, 2003–2007

	Aspirin	BB	ACE-I/ARB	Statins	Warfarin
Insured/non-HPSA	Referent	Referent	Referent	Referent	Referent
Insured/HPSA	1.19 (0.79–1.80)	1.05 (0.75–1.47)	1.08 (0.90–1.30)	1.01 (0.84–1.21)	1.42 (0.93–2.17)
Uninsured/non-HPSA	1.33 (0.66–2.64)	1.47 (0.78–2.74)	0.98 (0.75–1.28)	0.74 (0.57–0.96)	1.44 (0.65–3.21)
Uninsured/HPSA	0.92 (0.26–3.24)	1.01 (0.31–3.25)	0.98 (0.58–1.65)	0.54 (0.33–0.90)	***

ACE-I = angiotensin converting enzyme inhibitor, ARB = angiotensin receptor receptor blocker, BB = Beta Blockers, HPSA = Health Professional Shortage Area

^*Adjusted for age, race, gender, education, income, percent of county population below poverty, medication adherence, functional capacity, and depressive symptoms.

^**Among those with a qualifying condition as defined in Table 1.

^***Adjusted odds ratio not available due to an insufficient number of individuals to conduct multivariable analyses; unadjusted odds ratio = 0.14 (0.02–1.08).